Keyphrases
Cannabis
100%
Immune Checkpoint Inhibitors
100%
Non-small Cell Lung Cancer (NSCLC)
100%
Medical Cannabis
100%
Sigh
100%
Δ9-tetrahydrocannabinol (Δ9-THC)
30%
Pembrolizumab
23%
Deleterious Effects
15%
Confidence Interval
15%
Overall Survival
15%
Non-small Cell Lung Cancer Patients
15%
Anti-PD-1 Antibody
15%
First-line Monotherapy
15%
Clinical Outcomes
7%
First Month
7%
Cannabinoid Receptor 1 (CB1R)
7%
Preclinical Data
7%
Smoking Status
7%
Statistical Significance
7%
Histology
7%
Multivariate Analysis
7%
Cancer Patients
7%
Nave
7%
Clinical Setting
7%
Clinical Data
7%
Monotherapy
7%
Liver Metastasis
7%
Murine Model
7%
Tumor-bearing Mice
7%
Brain Metastases
7%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
7%
Metastatic Non-small Cell Lung Cancer
7%
Disease Burden
7%
Predictive Factors
7%
Metastatic Disease
7%
Immune Cells
7%
Reassurance
7%
Combination Treatment
7%
Cannabis Use
7%
Female Predominance
7%
Appetite Loss
7%
Median Overall Survival
7%
Inhibitor Efficiency
7%
Anti-PD-1 Therapy
7%
Eastern Cooperative Oncology Group
7%
CT26 Tumors
7%
Programmed Death-ligand 1 Expression
7%
Time to Tumor Progression
7%
Cancer Medication
7%
Medicine and Dentistry
Immune Checkpoint Inhibitor
100%
Cannabis
100%
Non Small Cell Lung Cancer
100%
Medical Cannabis
100%
Tetrahydrocannabinol
40%
Monotherapy
30%
Pembrolizumab
30%
Overall Survival
30%
Effects of Cannabis
30%
Malignant Neoplasm
20%
Multivariate Analysis
10%
Tumor Progression
10%
Neoplasm
10%
Oncology
10%
Metastatic Carcinoma
10%
Liver Metastasis
10%
Brain Metastasis
10%
Programmed Death 1 Ligand 1
10%
Disease Burden
10%
Immunocompetent Cell
10%
Loss of Appetite
10%
Reassurance
10%
Cannabis Use
10%
Cannabinoid Receptor
10%
Diseases
10%
Pharmacology, Toxicology and Pharmaceutical Science
Cannabis
100%
Immune Checkpoint Inhibitor
100%
Medical Cannabis
100%
Non Small Cell Lung Cancer
100%
Tetrahydrocannabinol
28%
Monotherapy
21%
Overall Survival
21%
Pembrolizumab
21%
Malignant Neoplasm
14%
Diseases
14%
Tumor Growth
7%
Neoplasm
7%
Programmed Death 1 Ligand 1
7%
Liver Metastasis
7%
Brain Metastasis
7%
Cannabinoid Receptor
7%
Loss of Appetite
7%